clinical

What the EDGE team are up to

Dave Osler EDGE

It’s been 2 months in lockdown now and our entire department is working from home, so I thought I’d take some time to bring everyone up to speed on what the EDGE team are up to.

Firstly, it hasn’t quite been the start that we hoped for our new developer Grant, a Doctor by training, which is a unique skill set that I am sure will be very valuable. He officially started with us whilst in lockdown, so although we’ve virtually met him, many of us haven’t yet met him in person. Although in the world of remote working and geographically diverse companies, perhaps it isn’t unusual for colleagues to have never met in person?

Our team have daily meetings, and in fact these often becomes multiple daily meetings between sub-groups of us as we work on different projects. Our concentration is heavily EDGE 3 development, using this time to concentrate on designing new specifications for functionality, as well as enhancements for the current functions EDGE 2 already provides. Functions are great, however a system is not built simply on functions. Usability is a very important aspect of systems and a functionally rich application is of little use if nobody can work out how to use it, or find it so confusing or complex that they end up looking for workarounds.

Our team are doing a lot of engaging with many of you to find out how you use the system and gather as much feedback as possible, as well as using the skills and knowledge of our departmental Psychologist Kenny. He is, at this moment, integrating data analysis around how users navigate throughout the system, which functions are most used, and how users navigate to those functions. There are a multitude of different types of people who use EDGE, each with different job roles, so although the search for absolute perfection may end up being fruitless, there are certainly a lot of improvements we already have lined up.

There is currently no fixed release date for EDGE 3, although we are aiming for sometime late in 2021. As we approach that time we can start to be more specific, however until then we have a lot of problems to solve, challenges to overcome, cans of worms to open, ducks to line up and all other types of analogy. However I am confident that EDGE 3 will be the product that we all are hoping for, both in terms of functions available to users, integration possibilities to other systems, and also importantly, a technologically up-to-date framework that allows our developers to continue building new and exciting functions at speed, something which is more difficult currently in EDGE 2.

Now for the sad news. The event of the year for many people, the eminent social and educational soiree that is the yearly EDGE conference is diverging from its usually perennial perpetualness. Or in other words, we’re moving it. Whilst we are in the throws of designing and building EDGE 3, it is perhaps better that we continue to concentrate on this, and when ready, create a conference specifically around the launch of the new version. Our marcoms team, Beth, Gela and Kenny will as always keep you all informed well before the event so that you can book your tickets before they sell out.

Be sure to visit the CIRU website for more information on other work taking place in our department, to keep up to date with what we are up to, or even to browse out staff pictures and put faces to the names of people you often speak with.

EDGE delegation log advances clinical trial management

EDGE delegation log image 2020.jpg

It has been great to hear recently that lots of organisations are making use of the electronic delegation log that EDGE has to offer. Especially due to recent times with everything that is going on with COVID-19, it can be even harder to track down those wet ink signatures.

The EDGE delegation log was developed a few years ago now to reduce the burden of paper logs and to make the whole signature process a lot easier. Where the log is easily accessible via EDGE it saves staff a lot of time by being able to access the log anywhere with a computer or device, they could be in their office, in clinic, or even on the go. This already saves research staff valuable time in which they can spend elsewhere, for example seeing and treating their patients. Having the log online also means everyone is working from one version and there is no chance of it getting lost like a paper one sometimes can.

User feedback has included how monitoring visits are a lot easier as the latest version is always the one on EDGE which can be viewed online or a printed copy made available if the site monitor prefers.

The delegation log is also improving communication across different teams and helping provide a better patient experience. One of the CRUK nurses based at Southampton hospital has told us how previously with a paper log they would sometimes have to leave the clinic or unit where they are treating patients to go back to their office, collect the log from the site file and take it over to pharmacy. Now, the nursing team are able to remain treating their patients whilst the pharmacy team can simply log onto EDGE and access the latest version themselves, meaning better communication and no interruption is caused to the patients being treated.

We already know that the delegation log is helping lots of teams work more efficiently and we envision over time the usage which continue to increase as more clinical teams become engaged with using the online version.

If you’re an EDGE user and want to know more about the delegation log, then please get in touch as we have a user guide and video available for more information. Email edgecomms@soton.ac.uk

Clinical Informatics Research Unit Update

resin logo.JPG

We would like to take this opportunity to give you all an update on what is happening here at the Clinical Informatics Research Unit (CIRU). 

We would like to warmly welcome Dr Mike Head and Dr Rebecca Brown into the department. They are both Research Fellows at the University of Southampton and are currently running the ResIn study.

The Research Investments in Global Health study (ResIn) is funded by the Bill & Melinda Gates Foundation. The project previously focused on the UK research landscape and published widely on the strengths and gaps in the UK research portfolio for both infectious diseases and oncology. Levels of investment have been compared to global and national burdens of disease to gain an insight into relative levels of spend and inform priority-setting initiatives. Now, ResIn is building a global dataset and analysing funding trends and disease burdens for infectious disease research across the G20 nations and will report findings in 2018. The study, and results to date, have been presented multiple times to many high-level global health stakeholders including the World Health Organisation, European Commission and the Wellcome Trust. Findings have also been cited by others in numerous documents including journal publications and government reports.

See http://researchinvestments.org/ for more about the project.